CD44 splice variants in draining lymph nodes precede allograft rejection of endocrine cells

被引:0
|
作者
K. F. Milde
P. Herrlich
H. Ponta
机构
[1] Forschungszentrum Karlsruhe,
[2] Institute of Genetics,undefined
[3] PO Box 3640,undefined
[4] D-76021 Karlsruhe,undefined
[5] Germany,undefined
来源
关键词
Key words Islets of Langerhans; Allogeneic transplantation; Rejection markers; CD44; Diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Upon allogeneic transplantation (Tx) of pancreatic islets under the kidney capsule of diabetic rats, cells from draining lymph nodes and, to a minor degree, bone marrow transiently upregulate CD44 splice variants as detected by RT-PCR using CD44 variant exon specific primers. Maximal expression was on day 5 post Tx in lymph nodes and thus precedes islet rejection sufficiently (in this model by 5 days) to still permit establishing rescue by immunosuppressive therapy. CD44 variant exon sequence could therefore serve as early markers of allograft rejection.
引用
收藏
页码:67 / 69
页数:2
相关论文
共 50 条
  • [41] Overexpression of specific CD44 variants mediate endocrine insensitivity and invasion in breast cancer cells
    Bellerby, Rebecca L.
    Smith, Christopher
    Gee, Julia
    Martin, Tracey
    Barrett-Lee, Peter
    Hiscox, Stephen
    CANCER RESEARCH, 2014, 74 (19)
  • [42] CD44 Splice Variants as Potential Players in Alzheimer's Disease Pathology
    Pinnera, Elhanan
    Gruper, Yaron
    Ben Zimra, Micha
    Kristt, Don
    Laudon, Moshe
    Naor, David
    Zisapel, Nava
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (04) : 1137 - 1149
  • [43] Kinetics of cellular traffic in the aqueous humour and draining lymph nodes in rat corneal allograft rejection
    Claerhout, I
    Kestelyn, P
    Beele, H
    Leclercq, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U619 - U619
  • [44] Identification of CD44 variants in canine cancer cells
    Kimura, Kento
    Tanabe, Atushi
    Tabuchi, Kensuke
    Sahara, Hiroeki
    CANCER SCIENCE, 2018, 109 : 1048 - 1048
  • [45] The influence of CD44 splice variants to the outcome of patients with oral squamous cell carcinoma
    Stoll, C
    Baretton, G
    Soost, F
    Lohrs, U
    CANCER GENE THERAPY, 1997, 4 (05) : 300 - 300
  • [46] Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas
    Stoll, C
    Baretton, G
    Soost, F
    Terpe, HJ
    Domide, P
    Löhrs, U
    ORAL ONCOLOGY, 1999, 35 (05): : 484 - 489
  • [47] IMMUNOHISTOCHEMICAL AND SEROLOGICAL EVALUATION OF CD44 SPLICE VARIANTS IN HUMAN OVARIAN-CANCER
    SLIUTZ, G
    TEMPFER, C
    WINKLER, S
    KOHLBERGER, P
    REINTHALLER, A
    KAINZ, C
    BRITISH JOURNAL OF CANCER, 1995, 72 (06) : 1494 - 1497
  • [48] SPLICE VARIANTS OF CD44 IN HUMAN CERVICAL-CANCER STAGE IB TO IIB
    KAINZ, C
    KOHLBERGER, P
    SLIUTZ, G
    TEMPFER, C
    HEINZL, H
    REINTHALLER, A
    BREITENECKER, G
    KOELBL, H
    GYNECOLOGIC ONCOLOGY, 1995, 57 (03) : 383 - 387
  • [49] The influence of CD44 splice variants to the outcome of patients with oral squamous cell carcinoma
    Stoll, C
    Baretton, G
    Soost, F
    Löhrs, U
    GENE THERAPY OF CANCER, 1998, 451 : 51 - 55
  • [50] Differential expression of CD44 splice variants in the normal human central nervous system
    Kaaijk, P
    Pals, ST
    Morsink, F
    Bosch, DA
    Troost, D
    JOURNAL OF NEUROIMMUNOLOGY, 1997, 73 (1-2) : 70 - 76